ACM-SARS-CoV-2-beta ACM-CpG vaccine candidate

N/A

Report date: 2023/09/06 14:40:19

Base Information

Drug NameACM-SARS-CoV-2-beta ACM-CpG vaccine candidate

Drug Alias NameACM-001

ClassificationVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesACM Biolabs Pte Ltd

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A